نتایج جستجو برای: mtor

تعداد نتایج: 16868  

2007
Romain Parent Deepak Kolippakkam Garrett Booth Laura Beretta

The mammalian target of rapamycin (mTOR) pathway, a major regulator of translation, is frequently activated in hepatocellular carcinomas. We investigated the effects of mTOR activation in the human HepaRG cells, which possess potent hepatocytic differentiation capability. Differentiation of HepaRG cells into functional and polarized hepatocyte-like cells correlated with a decrease in mTOR and A...

2017
Zixuan Zhang Mengzhao Wang

The present study examined the expression of mammalian target of rapamycin (mTOR) and mutations in the phosphoinositide 3-kinase (PI3K)/AKT/mTOR pathway in 54 patients with typical carcinoid tumours (TC) or atypical carcinoid tumours (AC). In total, 54 bronchopulmonary neuroendocrine tumour (NET) surgical specimens, consisting of 17 TC, 8 AC, 17 large-cell neuroendocrine carcinoma (LCNEC), and ...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2013
Yevgeny Berdichevsky Alexandra M Dryer Yero Saponjian Mark M Mahoney Corrin A Pimentel Corrina A Lucini Marija Usenovic Kevin J Staley

mTOR is activated in epilepsy, but the mechanisms of mTOR activation in post-traumatic epileptogenesis are unknown. It is also not clear whether mTOR inhibition has an anti-epileptogenic, or merely anticonvulsive effect. The rat hippocampal organotypic culture model of post-traumatic epilepsy was used to study the effects of long-term (four weeks) inhibition of signaling pathways that interact ...

2015
Hiroyuki Yamaguchi Masahito Kawazu Takahiko Yasuda Manabu Soda Toshihide Ueno Shinya Kojima Masakazu Yashiro Ichiro Yoshino Yuichi Ishikawa Eirin Sai Hiroyuki Mano

Mammalian target of rapamycin (mTOR) is a serine-threonine kinase that acts downstream of the phosphatidylinositol 3-kinase signaling pathway and regulates a wide range of cellular functions including transcription, translation, proliferation, apoptosis, and autophagy. Whereas genetic alterations that result in mTOR activation are frequently present in human cancers, whether the mTOR gene itsel...

Journal: :Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2018
Jordan B Jahrling Ai-Ling Lin Nicholas DeRosa Stacy A Hussong Candice E Van Skike Milena Girotti Martin Javors Qingwei Zhao Leigh Ann Maslin Reto Asmis Veronica Galvan

We recently showed that mTOR attenuation blocks progression and abrogates established cognitive deficits in Alzheimer's disease (AD) mouse models. These outcomes were associated with the restoration of cerebral blood flow (CBF) and brain vascular density (BVD) resulting from relief of mTOR inhibition of NO release. Recent reports suggested a role of mTOR in atherosclerosis. Because mTOR drives ...

Journal: :The Journal of clinical investigation 2010
Jianhui Ma Yan Meng David J Kwiatkowski Xinxin Chen Haiyong Peng Qian Sun Xiaojun Zha Fang Wang Ying Wang Yanling Jing Shu Zhang Rongrong Chen Lianmei Wang Erxi Wu Guifang Cai Izabela Malinowska-Kolodziej Qi Liao Yuqin Liu Yi Zhao Qiang Sun Kaifeng Xu Jianwu Dai Jiahuai Han Lizi Wu Robert Chunhua Zhao Huangxuan Shen Hongbing Zhang

The receptor tyrosine kinase/PI3K/AKT/mammalian target of rapamycin (RTK/PI3K/AKT/mTOR) pathway is frequently altered in cancer, but the underlying mechanism leading to tumorigenesis by activated mTOR remains less clear. Here we show that mTOR is a positive regulator of Notch signaling in mouse and human cells, acting through induction of the STAT3/p63/Jagged signaling cascade. Furthermore, in ...

Journal: :Oncology reports 2010
Zhi Gang Wang Takuya Fukazawa Toshio Nishikawa Nobuyuki Watanabe Kazufumi Sakurama Takayuki Motoki Shinji Hatakeyama Osamu Omori Toshiaki Ohara Shunsuke Tanabe Yasuhiro Fujiwara Munenori Takaoka Yasuhiro Shirakawa Tomoki Yamatsuji Noriaki Tanaka Yoshio Naomoto

Esophageal cancer is one of the most frequently occurring cancers in the world. Targeting therapy strategy of cancer with specific inhibitors is developing and has showed promising antitumor efficacy. It is known that mTOR is an important controller of cell growth. RAD001 (everolimus) is a specific inhibitor of mTOR that can block the mTOR signaling pathway. The purposes of this study was to ex...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2014
Do-Hun Lee Xueting Luo Benjamin J Yungher Eric Bray Jae K Lee Kevin K Park

Mammalian target of rapamycin (mTOR) functions as a master sensor of nutrients and energy, and controls protein translation and cell growth. Deletion of phosphatase and tensin homolog (PTEN) in adult CNS neurons promotes regeneration of injured axons in an mTOR-dependent manner. However, others have demonstrated mTOR-independent axon regeneration in different cell types, raising the question of...

2014
Nobuyuki Takei Hiroyuki Nawa

Target of rapamycin (TOR) was first identified in yeast as a target molecule of rapamycin, an anti-fugal and immunosuppressant macrolide compound. In mammals, its orthologue is called mammalian TOR (mTOR). mTOR is a serine/threonine kinase that converges different extracellular stimuli, such as nutrients and growth factors, and diverges into several biochemical reactions, including translation,...

Journal: :International journal of molecular medicine 2015
Lingxia Li Xiaochuang Wang Lina Wang Li Qu Xinye Zhu Manxiang Li Xiaoyan Dang Ping Li Yanxia Gao Zhuo Peng Longfei Pan Li Wan

Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disorder with high morbidity and mortality, and is characterized by excessive growth of endothelial cells. Recently, the mammalian target of rapamycin (mTOR) has attracted increasing attention due to its potential as a therapeutic target against certain diseases associated with proliferative and metabolic abnormalities. H...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید